Xiaoyang Dou

机构：Howard Hughes Medical Institute, University of Chicago, Center for Excellence in Molecular Cell Science · ORCID：0000-0003-3742-1813

发表论文 42 篇 · 总被引 3144 次 · h-index 21

代表论文

• YTHDF2 inhibition potentiates radiotherapy antitumor efficacy (2023 · Cancer Cell · 被引 250)
• Exon architecture controls mRNA m 6 A suppression and gene expression (2023 · Science · 被引 248)
• RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation (2023 · Nature Cell Biology · 被引 90)
• RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis (2024 · Nature · 被引 85)
• METTL14 is a chromatin regulator independent of its RNA N 6 -methyladenosine methyltransferase activity (2023 · Protein & Cell · 被引 83)
• Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration (2023 · Nature Neuroscience · 被引 78)